Naïve Library Panning

AtaGenix’s naïve library technology enables rapid antibody discovery with high diversity (up to 10¹⁰ variants) while eliminating the need for animal immunization. Compared to hybridoma technology, our phage display approach reduces turnaround time to 3-4 months and removes the need for further humanization, ensuring efficient and cost-effective therapeutic antibody development.

Rapid Antibody Screening

Select high-affinity antibodies within 3-4 months, twice as fast
Animal-Free & Ethical

No animal immunization, fully human naïve library screening
No Further Humanization Needed

Direct selection of fully human antibodies, reducing costs

Available Naïve Libraries at AtaGenix

Library	Format	Species	Size (clones)
NEW! LiAb-SFCOVID-19™	scFv	Human – COVID-19 recovered donors	1.19 × 10¹⁰
LiAb-SFMAX™	scFv & Fab	Human – 5 ethnic groups, 368 donors	5.37 × 10¹⁰
LiAb-SFa™	scFv	Human	1.5 × 10⁹
LiAb-Fab™	Fab	Human	2.00 × 10¹⁰
NEW! LiAb-VHHMAX™	VHH	Camel, llama, alpaca – 57 animals	1.51 × 10¹⁰
LiAb-SFRab™	scFv & Fab	Rabbit – 4 breeds for diversity	1.09 × 10¹⁰
LiPep-12	Peptide 12-mer	/	1.00 × 10⁹
LiPep-7	Peptide 7-mer	/	1.00 × 10⁹

Biopanning Protocol in Phage Display

Example of the **panning (biopanning) protocol** in **Phage Display**:

Step 1: Incubation with phage library
Step 2: Wash away non-binders
Step 3: Elution of binders
Step 4: 3 to 5 rounds of panning/biopanning process
Step 5: ELISA to determine specificity of binding

By Method

By Application

Naïve Library Panning

Available Naïve Libraries at AtaGenix

Biopanning Protocol in Phage Display

Ask us

About us

Core Technologies

Resource Center